Commercial Space Company Risk / Opportunity Ranking

Thesis: There is limited relevance support that Kurs Orbital is an operating in-orbit servicing company, which could fit a long-horizon commercial space opportunity framework, but the evidence is only undated directory-style article context rather than direct company-specific positive events or facts.

Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain.

Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided.

Thesis: The reviewed sources rationale says Leidos delivered a cloud-based Joint Management Tool to DISA for SATCOM visibility and modernization, suggesting a role in defense SATCOM infrastructure, but no within the recent evidence window evidence are available to support a stronger long-horizon opportunity thesis.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

Thesis: LeoLabs is described in membership rationale as deploying radar for space domain awareness with Space Force/SpaceWERX support, which is strategically relevant, but no available direct evidence support a stronger opportunity call.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

Thesis: Older context suggests strategic optionality from self-funding an Earth-observation constellation of 20 radar and IR imagers, but this evidence is outside the 90-day recent evidence window and therefore insufficient for a strong current ranking.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

Thesis: The reviewed sources membership rationale references space and defense satellite activity that could support long-term opportunity, but no usable recent evidence window-valid evidence are available here.

Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view.

Thesis: The membership rationale says Lux Aeterna completed a $10 million seed financing and is building a fully reusable satellite platform, which is directionally positive, but the reviewed sources contain no retained within the recent evidence window article evidence or to support a stronger thesis.

Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions.

Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row.

Thesis: The reviewed sources say Lynk Global was listed as a payload on a Falcon 9 rideshare mission, which hints at tangible space activity and gives slightly more concrete relevance than pure market-list context, but it still does not establish a supported long-horizon opportunity thesis without direct evidence or.

Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and

Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only.

Thesis: There is weak potential opportunity from the reviewed sources' membership rationale that MBRYONICS was a partner on an ESA optical communications project, but the ranking reviewed sources contain no kept direct evidence or citable for that claim.

Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation.

Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty.

Thesis: The reviewed sources rationale says Mercury supplies solid-state data recorders for SDA tracking satellites, which supports space-program exposure, but there are no retained within the recent evidence window evidence to confirm timing, scale, or durability.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

Thesis: The reviewed sources rationale says Meridian Space is a broadband constellation for which 280 satellites are being built, which suggests strategic scale potential, but the actual article evidence is not surfaced in the reviewed sources fields used for ranking, so opportunity support is limited.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

Thesis: Only a weak opportunity case is supported: undated external article-context lists Motiv Space Systems as an operating in-orbit servicing and assembly company, which suggests continued relevance to the sector but does not prove current growth, contracts, or milestones.

Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied.

Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources.

Thesis: Membership rationale describes Mynaric as a laser optical communications terminal provider acquired by Rocket Lab, which implies strategic relevance to space communications hardware, but no direct evidence within the recent evidence window are available to support a durable opportunity call.

Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here.

Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps.

Thesis: The reviewed sources rationale says Mynaric is an acquired laser optical communications company, indicating potentially strategic technology relevance, but there is no direct positive evidence row, quote, or to support a durable opportunity thesis.

Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or

Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only.

Thesis: N SPACE TECH has thematic relevance because the membership rationale profiles it as an Indian aerospace/defense startup designing CubeSats, RF subsystems, radars, and antennas and working with ISRO and DRDO, but the reviewed sources contain no retained 90-day evidence to convert that profile into a current opportunity thesis.

Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference.

Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity.

Thesis: The reviewed sources includes one external article summary saying NASA awarded Nanoracks a $160 million contract to develop a commercial space station, which is strategically positive if still relevant, but the article is dated September 2, 2025 and was dropped by the 90-day recent evidence window, so support for a current 1 year+ opportunity ranking is weak.

Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff.

Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window.

Thesis: Reviewed evidence membership rationale says NordSpace is a private Canadian aerospace/defence startup awarded defense funding for a VLEO satellite concept and planning launches from its own spaceport complex, which would be strategically relevant if current, but no direct evidence or article summaries survived the available recent evidence window in these reviewed sources, so opportunity cannot be ranked highly on evidence alone, unavailable in reviewed sources).

Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources.

Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources.

Thesis: There is not enough in-window evidence in this specific row to support a strong positive thesis beyond generic cohort relevance.

Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources.

Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments.

Thesis: OHB may have long-horizon opportunity through satellite manufacturing and in-orbit testing infrastructure exposure, as the membership rationale says Mimir 1 was built by OHB Sweden, but there is no retained 90-day evidence in the reviewed sources to support a current ranking catalyst.

Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state.

Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view.

Thesis: Phase-2 rationale says Optera received UK space-sector early-stage funding and additional private capital, which could be positive if confirmed, but the current reviewed sources retains no in-window evidence to support a stronger ranking.

Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources.

Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own.

Thesis: Reviewed evidence membership rationale says Paladin Space is partnering to offer debris removal as a service using its Triton payload, which suggests exposure to on-orbit servicing and sustainability themes over a long horizon, but no citeable direct evidence are provided.

Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress.

Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence.

Thesis: No negative thesis can be established because no direct negative evidence for Apparition Geoservices GmbH is available in the reviewed sources after recent evidence filtering.

Why now: No current business-state change or catalyst is visible. Although 6 articles were considered, coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window, while the membership review says the reviewed sources are only a broad European tech funding roundup without a direct company-specific description.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Mention count and article count do not increase conviction because no post-recent evidence window evidence are available. Review-status rationale says retrieval context is insufficient for membership.

Thesis: No negative thesis is supported because Arkeon has no direct negative evidence in the reviewed sources within the selected recent evidence window.

Why now: No company-specific timing signal is visible. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says only a generic funding-roundup article was available without a company-specific description tying Arkeon to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event, fact, or negative development is available after recent evidence window. Low membership confidence is not directional evidence.

Thesis: No negative thesis can be formed because the reviewed sources includes no direct negative evidence for Ars Magna Semiconductors within the recent evidence window.

Why now: There is no visible long-horizon strategic catalyst in the usable evidence. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a general tech funding roundup without a company-specific description linking the company to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct positive or adverse operating evidence is available. Generic roundup context is weaker than company-specific evidence and is not directional proof.

Thesis: No negative thesis is supportable because the reviewed sources have no direct negative evidence for Augusta Labs after recent evidence filtering.

Why now: No current or durable catalyst can be identified from the reviewed sources. Coverage debug shows zero post-recent evidence window articles and evidence, and the membership note says the company is only present in a generic funding-roundup article without direct identification against the listed criteria.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Absence of risk evidence is not positive evidence. No direct company-specific facts or events are available.

Thesis: No negative thesis can be justified because no direct negative evidence for BeatpulseLabs is present in the reviewed sources within the recent evidence window.

Why now: There is no visible catalyst or deterioration signal. Coverage debug shows zero post-recent evidence window articles and evidence, and the only cited support is a generic funding-roundup article with no direct company-specific connection to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article No direct event or fact evidence is available after recent evidence window. Generic context should not be treated as directional proof.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Bose Corporation after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 97 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; despite broad article consideration, nothing survived the time/evidence filters for a 1 year+ thesis judgment.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Breaking Change after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 3 articles considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says the reviewed sources gives no meaningful company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative thesis can be supported because there is no direct negative evidence for CameraMatics in the reviewed sources after recent evidence filtering.

Why now: No company-specific catalyst is visible despite 6 articles considered, because coverage debug shows 0 articles after recent evidence window and 0 evidence after recent evidence window. The membership note says the reviewed sources only includes CameraMatics in a generic funding roundup with no direct statement tying it to the scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Article count does not create conviction because no post-recent evidence window evidence are available. No direct positive or adverse company-specific event is available.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Camphouse after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic roundup mention was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for Capsa AI after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for CardNexus after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says the reviewed sources does not provide direct company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative/risk thesis can be supported because the reviewed sources contain no direct negative evidence for CeQur after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse events or facts are retained after recent evidence window.

Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article, but the reviewed sources does not include the article summary or retained evidence. Supplier relevance to the space ecosystem does not by itself justify an opportunity score without current retained evidence. Recency is uncertain because the supporting substantive claims are not preserved in the recent evidence window evidence set.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse direct evidence remains after recent evidence window.

Why now: There is no current why-now signal in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the actual retained evidence is absent from these reviewed sources. The rationale itself frames IHI more as a beneficiary/customer than clearly as the core space operator, which weakens directional use even if the older article were available.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because there are no direct negative evidence and no articles retained after the 90-day recent evidence window.

Why now: There is no current why-now signal in the reviewed evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after dedupe/recent evidence window.

Caveats: Phase-2 rationale references article: but that article content is not provided here and no retained evidence remain after recent evidence window. Membership review status is not directional proof. Absence of evidence should not be interpreted as absence of business activity.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no adverse evidence remains after the 90-day recent evidence window.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite substantial historical article count.

Caveats: Phase-2 rationale references articles: and: but their content is not included here. Historical mention density is not conviction. Public listing/ticker presence does not create a directional thesis without retained evidence.

Thesis: No negative thesis is supportable from retained reviewed sources evidence because no negative events or facts are retained after recent evidence window.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the underlying article details are not included here. A referenced letter of intent, without retained evidence details or timing, is insufficient for a 1 year+ directional ranking. Private-company status may limit visibility, but that is not itself a thesis.

Thesis: No negative thesis can be supported from the reviewed sources because there is no direct negative evidence available for Zone14 within the 90-day recent evidence window.

Why now: There is no current company-specific catalyst visible in the reviewed sources. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window for Zone14; the membership note says it appears only through a broad funding roundup and lacks company-specific evidence tied to the listed scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. Company appears only in review status with low membership confidence, which is not directional evidence.